0
likes
0
comments
daily view 0
monthly view 0

Share

Live Analytics

Comments 0

The effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention Analytics Table

Income Estimates for The effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention

Based on this YouTube video's total view count of 81 views and industry-standard rates, the estimated total earning is $0 - $0 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

About The effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention

Explore The effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention with 81 views, 0 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.

Verapamil has a wide range of dosing in primary headache disorders, but there is no reliable way to predict the effective and tolerable doses for an individual. Yi-Chieh Chen, PharmD, Mayo Clinic, Rochester, MN, discusses a pilot study investigating the factors affecting the efficacy and safety of verapamil for migraine using pharmacogenomic reports in electronic medical records (EMRs). This retrospective study investigated 33 adult patients who had used verapamil for migraine and had a pharmacogenomic report in the EMRs. Results showed a wide range of minimum effective (range 20 to 320 mg) and maximum tolerable (range 20 to 480 mg) verapamil doses. The study also investigated six metabolic enzymes relevant to verapamil. Most patients were CYP1A2 rapid metabolizers, CYP2B6 intermediate metabolizers, and CYP3A4 normal metabolizers. There was a wide variety of CYP2C9, CYP2D6, and CYP3A5 phenotypes. However, after adjusting for age, sex, BMI, and smoking status, there was no association between different phenotypes and verapamil doses. The pilot study demonstrated that there was a wide range of minimum effective and maximum tolerable verapamil doses in patients with a variety of pharmacogenomic phenotypes in migraine prevention – however, the use of a small sample size and utilizing an existing pharmacogenomic report were limiting factors. This interview took place during the 2022 American Headache Society (AHS) Meeting in Denver, CO.

About YouTube Real-Time View Count

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.

Embed Widget

Parameters:

  • fullscreen=true - Fullscreen counter
  • graph=true - Live graph chart
  • counter=0/1/2 - Select counter (0=likes, 1=views, 2=comments)
URL

Click to copy the embed URL to your clipboard